Rishi Kapoor has joined Biodeal Pharmaceuticals Limited as the company’s new Chief Financial and Business Officer (CFBO), bringing over two decades of strategic financial leadership across Pharma & Healthcare, EdTech, IT, and Retail sectors. In his new role, Rishi will spearhead Biodeal’s financial strategy, drive investor engagement, and lead the company’s upcoming IPO journey, while focusing on automation of financial processes to strengthen the organization’s foundation.
Rishi joins Biodeal with an impressive career portfolio, having held key leadership roles at Girnar Group, Corbus LLC, Amrapali Group, Future Group, and Max Healthcare. He has extensive experience in strategic finance, fundraising, M&A, IPO management, and investor relations, successfully driving high-value acquisitions and integrations across multiple geographies. His exceptional achievements were recently recognized when he was named one of India’s Top 10 Most Dynamic Revenue and Growth Leaders 2025 by TradeFlock.
Before Biodeal, Rishi served as Chief Revenue Officer and General Manager – Finance at CollegeDekho, where he played a pivotal role in new business development, revenue assurance, and enterprise-level financial management. His earlier tenures included leadership positions at Corbus LLC, Amrapali Apparels, Max Healthcare, Future Generali India Life Insurance, and EY, equipping him with a diverse and deep understanding of corporate finance, accounting, and operational strategy.
A Chartered Accountant, Master in Finance, and Lifetime Certified Independent Director, Rishi is known for translating complex financial strategies into actionable business outcomes. His leadership is expected to further strengthen Biodeal Pharmaceuticals’ strategic positioning, drive financial excellence, and accelerate growth across the organization.